Stocks and Investing Stocks and Investing
Tue, October 29, 2019
Mon, October 28, 2019
Fri, October 25, 2019
Thu, October 24, 2019
Wed, October 23, 2019

Ian Somaiya Maintained (BIIB) at Hold with Increased Target to $297 on, Oct 23rd, 2019


Published on 2024-10-26 17:13:24 -
  Print publication without navigation


Ian Somaiya of BMO Capital, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $250 to $297 on, Oct 23rd, 2019.

Ian has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, all agrees with Ian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $250 on, Friday, June 28th, 2019